HealthDay News — After SARS-CoV-2 infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute sequalae of SARS-CoV-2 (PASC), according to a study published ...
FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.
Findings showed treatment with Rybrevant plus chemotherapy significantly reduced the risk of disease progression or death by 52% compared with chemotherapy.
HealthDay News — Americans have the worst health care among the world’s wealthy nations, a new report says. People in the US die the earliest and live the sickest lives out of 10 developed countries, ...
The Food and Drug Administration (FDA) has approved Miplyffa ™ (arimoclomol) for use in combination with miglustat for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) ...
Baloxavir marboxil significantly reduced the likelihood of influenza transmission from the infected patient to the household contacts. Treatment with baloxavir marboxil significantly reduced the risk ...
HealthDay News — There are discrepancies between preferred and actual sources of contraceptive information for US adolescents and young adults (AYA), according to a research letter published online ...
HealthDay News — The demand for psilocybin-assisted therapy (PSIL-AT) for major depressive disorder (MDD) and treatment-resistant depression (TRD) varies from 24 to 62 percent depending on the ...